Driehaus Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-297,252
| Closed | -$4.29M | – | 413 |
|
|
2022
Q3 | $4.29M | Buy |
+297,252
| New | +$4.29M | 0.06% | 283 |
|
|
2021
Q2 | – | Sell |
-352,717
| Closed | -$10.7M | – | 534 |
|
|
2021
Q1 | $10.7M | Buy |
352,717
+67,849
| +24% | +$2.05M | 0.16% | 196 |
|
|
2020
Q4 | $14.1M | Sell |
284,868
-13,345
| -4% | -$661K | 0.23% | 125 |
|
|
2020
Q3 | $11.4M | Sell |
298,213
-35,647
| -11% | -$1.37M | 0.24% | 120 |
|
|
2020
Q2 | $14.4M | Sell |
333,860
-110,576
| -25% | -$4.78M | 0.35% | 90 |
|
|
2020
Q1 | $11.6M | Sell |
444,436
-2,806
| -0.6% | -$73.2K | 0.39% | 71 |
|
|
2019
Q4 | $14M | Buy |
447,242
+240,153
| +116% | +$7.5M | 0.37% | 74 |
|
|
2019
Q3 | $5.4M | Buy |
207,089
+7,246
| +4% | +$189K | 0.18% | 145 |
|
|
2019
Q2 | $4.57M | Buy |
+199,843
| New | +$4.57M | 0.14% | 171 |
|